Search by Drug Name or NDC

    NDC 61919-0593-30 CHLORDIAZEPOXIDE 25 mg/1 Details

    CHLORDIAZEPOXIDE 25 mg/1

    CHLORDIAZEPOXIDE is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE.

    Product Information

    NDC 61919-0593
    Product ID 61919-593_85b6b71f-54fb-8262-e053-2a91aa0a0f89
    Associated GPIs 57100020100115
    GCN Sequence Number 003735
    GCN Sequence Number Description chlordiazepoxide HCl CAPSULE 25 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14032
    HICL Sequence Number 001610
    HICL Sequence Number Description CHLORDIAZEPOXIDE HCL
    Brand/Generic Generic
    Proprietary Name CHLORDIAZEPOXIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CHLORDIAZEPOXIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, GELATIN COATED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name CHLORDIAZEPOXIDE HYDROCHLORIDE
    Labeler Name DIRECT RX
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA085475
    Listing Certified Through 2023-12-31

    Package

    NDC 61919-0593-30 (61919059330)

    NDC Package Code 61919-593-30
    Billing NDC 61919059330
    Package 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61919-593-30)
    Marketing Start Date 2019-04-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 2f1d49ad-13cb-2a23-e054-00144ff88e88 Details

    Revised: 4/2019